Market Dynamics: In 2021, the global postpartum market demonstrated significant strength and is poised to achieve a rapid revenue Compound Annual Growth Rate (CAGR) throughout the forecast period. The growth in revenue of the postpartum market is primarily fueled by the increasing prevalence of postpartum depression in women on a global scale.
Postpartum depression, a term encompassing a complex interplay of emotional, physical, and behavioral changes following childbirth, results in mood disorders for many women. The primary cause of postpartum depression lies in the chemical and physical changes occurring in a woman's body after delivery.
Factors Driving Market Growth: Drivers: A major catalyst propelling the growth of the postpartum depression market is the escalating prevalence of postpartum depression in women. As per a study published in Translational Psychiatry on October 20, 2021, covering 80 countries, approximately 17.22% of women suffer from postpartum depression.
Type Outlook (Revenue, USD Billion; 2019-2030):
• Postpartum Blues
• Postpartum Psychosis
• Postpartum Depression
• Postpartum Obsessive-Compulsive Disorder
• Postpartum Post-Traumatic Stress Disorder
• Postpartum Panic Disorder
Treatment Outlook (Revenue, USD Billion; 2019-2030):
• Antidepressants
• Antipsychotics
• Sleeping Pills
Get a sample copy of the Postpartum Depression Market report: https://www.reportsanddata.com/download-free-sample/5208
Other factors contributing to the expansion of the postpartum depression market include technological advancements in research and development for novel drug therapies addressing postpartum depression.
Restraints: A lack of knowledge and ignorance regarding the symptoms of postpartum depression constitutes a significant hindrance to the market's growth. Additionally, the high cost of available treatments poses another constraint to the growth of postpartum depression.
Opportunities: Technological advancements in drug development techniques for postpartum depression treatment and increased investments in healthcare are expected to contribute to lucrative growth in the forecast period.
Geographic Market Scenario: Largest Market Share: The North American market has emerged as the largest, boasting the highest revenue share. Market growth in this region is attributed to rising healthcare expenditure, increasing awareness, and a growing incidence of postpartum depression.
Fastest Growing Market: The Asia Pacific market is anticipated to experience the fastest growth during the forecast period. Factors such as a rising number of women with postpartum depression, government initiatives promoting awareness, and an increased demand for treatment contribute to the market's growth in this region. The presence of a large population is another factor expected to positively impact the postpartum depression market.
Key Market Trends and Innovation: Major Companies in the Market:
• SHIONOGI & Co., Ltd.
• Alvogen
• Intas Pharmaceuticals Ltd.
• Accord Healthcare
• Eli Lilly and Company
• Hoffmann-La Roche Ltd.
• Pfizer Inc.
• Bayer AG
• GlaxoSmithKline plc.
• Novartis AG
• Johnson & Johnson Private Limited
• AstraZeneca
• Lupin Pharmaceuticals, Inc.
• Sun Pharmaceutical Industries Ltd.
• Sanofi
• Merck & Co., Inc.
What Our Report Provides and Why Our Offering Is Better: This report offers historical data points, forecasts, and revenue growth at a global, regional, and country level. It provides analysis, industry trends, and consumption pattern details for each region, major country, and segment from 2019 to 2030. The global market report includes industry trends, drivers, restraints, opportunities, threats, market strategies, segment revenue, and revenue share contribution by each regional and country market. Additionally, the report offers industry analysis, a competitive landscape, company financials, and impact analysis.
Supportive Treatment Outlook (Revenue, USD Billion; 2019-2030):
• Cognitive Behavior Therapy
• Interpersonal Therapy
• Psychodynamic Therapy
Product Outlook (Revenue, USD Billion; 2019-2030):
• Tablet
• Pills
• Suspension
• Syrups
• Injectable
Dosage Form Outlook (Revenue, USD Billion; 2019-2030):
• Solid
• Liquid
Route of Administration Outlook (Revenue, USD Billion; 2019-2030):
• Oral
• Parenteral
End User Outlook (Revenue, USD Billion; 2019-2030):
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• Therapy Centers
Distribution Channel Outlook (Revenue, USD Billion; 2019-2030):
• Online
• Offline
Regional Outlook (Revenue, USD Million; 2019-2030):
• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Sweden
• BENELUX
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of APAC
• Latin America
• Brazil
• Rest of LATAM
• Middle East & Africa
• Saudi Arabia
• UAE
• South Africa
• Israel
• Rest of MEA
Explore Trending Reports:
Video Telemedicine Market-https://www.globenewswire.com/news-release/2020/05/07/2029527/0/en/Video...
ATP Assays Market-https://www.globenewswire.com/en/news-release/2021/03/17/2194783/0/en/AT...
Regenerative Medicine Market-https://www.globenewswire.com/en/news-release/2021/01/18/2159990/0/en/Re...
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/5208
Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press Release: https://www.reportsanddata.com/press-release
The First and Biggest Business SNS Company World Wide. Free and Unlimited!